Submit Deal
All corporates
Similar corporates
Deals Overview
Market Context
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Manos Perros
CEO
Kyle Dow
Press Contact
Deals
Service Providers
Relationships
Portfolio (2)
Team
Sort
entasis therapeutics limited
HQ - United States
Biotechnology
5 Sep 2017
Investment Date
n/a
Deal Value
11 Jul 2022
40%
Stake
£ 36 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy